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Abstract
We examined the relationship between grip strength declines and muscle-tendon responses induced by long-term
performance of a high-repetition, low-force (HRLF) reaching task in rats. We hypothesized that grip strength declines would
correlate with inflammation, fibrosis and degradation in flexor digitorum muscles and tendons. Grip strength declined after
training, and further in weeks 18 and 24, in reach limbs of HRLF rats. Flexor digitorum tissues of reach limbs showed low-
grade increases in inflammatory cytokines: IL-1b after training and in week 18, IL-1a in week 18, TNF-a and IL-6 after training
and in week 24, and IL-10 in week 24, with greater increases in tendons than muscles. Similar cytokine increases were
detected in serum with HRLF: IL-1a and IL-10 in week 18, and TNF-a and IL-6 in week 24. Grip strength correlated inversely
with IL-6 in muscles, tendons and serum, and TNF-a in muscles and serum. Four fibrogenic proteins, TGFB1, CTGF, PDGFab
and PDGFbb, and hydroxyproline, a marker of collagen synthesis, increased in serum in HRLF weeks 18 or 24, concomitant
with epitendon thickening, increased muscle and tendon TGFB1 and CTGF. A collagenolytic gelatinase, MMP2, increased by
week 18 in serum, tendons and muscles of HRLF rats. Grip strength correlated inversely with TGFB1 in muscles, tendons and
serum; with CTGF-immunoreactive fibroblasts in tendons; and with MMP2 in tendons and serum. Thus, motor declines
correlated with low-grade systemic and musculotendinous inflammation throughout task performance, and increased
fibrogenic and degradative proteins with prolonged task performance. Serum TNF-a, IL-6, TGFB1, CTGF and MMP2 may
serve as serum biomarkers of work-related musculoskeletal disorders, although further studies in humans are needed.
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Introduction
According to the Bureau of Labor Statistics report entitled
Nonfatal Occupational Injuries and Illnesses Requiring Days
Away from Work, 2011, musculoskeletal disorders accounted for
33 percent of all lost work time workplace injuries and illnesses in
the U.S. and required a median of 11 days away from work [1].
Studies in humans with upper extremity work-related musculo-
skeletal disorders find evidence of inflammation, fibrosis and
degeneration in serum and musculotendinous tissues, changes
thought to induce concurrent motor dysfunction [2–8]. However,
the pathophysiological responses are still under investigation,
particularly responses associated with chronic myopathies and
tendinopathies, as are serum biomarkers that might aid in
pinpointing the stage of these disorders.
An inflammatory response in musculoskeletal tissues has been
considered an important element in the pathogenesis of upper
extremity soft tissue disorders [8–10]. A small number of studies
have searched for and detected serum biomarkers of inflammation
in patients with upper extremity musculoskeletal disorders of short
duration (,3 months), including C-reactive protein, interleukin- 6
(IL-6), tumor necrosis factor-alpha (TNF-a), and members of the
IL-1 family [2,3,4]. The results of these studies suggest a role for
inflammatory cytokines early in the course of upper extremity
MSDs. However, tissues collected from patients with upper
extremity MSDs at the time of surgical intervention show
increased IL-1b immunoreactive fibroblasts and IL-6 (which can
be pro- or anti-inflammatory depending on accompanying
cytokines) [11–13], but few acute inflammatory responses [7,11].
Interestingly, IL-6, IL-1b and TNF-a have also been deemed as
pro-fibrotic cytokines due to their mitogenic and chemotactic
effects on fibroblasts and induction of fibrogenic proteins [14–19].
A few studies examining serum of workers have also detected
increased serum biomarkers of collagen turnover in response to
prolonged exposure to heavy physical loads. Increased serum
markers of collagen type I synthesis (PINP; N-terminal propeptide
type I procollagen) and degradation (CTX1; C-telopeptide of type
I collagen) were identified in workers employed in heavy manual
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lifting jobs [20–22], although the overall ratio of these synthesis to
degradation markers remained the same in male construction
workers as in workers with sedentary jobs. These results indicate
that stressed tissues can adapt to the needs of a particular job,
increasing collagen synthesis to match that of collagen degrada-
tion. However, studies examining tendosynovial tissues collected
from patients with upper extremity musculoskeletal disorders
during surgical intervention show increased tissue fibrogenic and
degradative proteins (e.g., transforming growth factor beta 1 and
matrix metalloproteases) and fibrotic histopathology
[7,11,23,24,25]. These latter findings are indicative of deranged
extracellular matrix production and degeneration in tissues by the
time of surgical intervention, rather than tissue adaptation.
Transforming growth factor beta 1 (TGFB1) and connective
tissue growth factor (CTGF/CCN2) are important mediators of
fibrosis. TGFB1 has been implicated as a sensitive serum
biomarker of fibrogenic tissues changes [26]. Levels of CTGF/
CCN2 in patients with scleroderma or other fibrotic disorders
correlate positively with disease severity [27,28]. Both are key
mediators of tissue remodeling and fibrosis that work synergisti-
cally to generate sustained fibrosis [29,30]. Serum matrix
metalloproteases (MMPs) have also been indicated as sensitive
serum biomarkers of pathological collagen remodeling occurring
with osteoarthritis, ankylosing spondylitis, heart failure due to
deranged myocardial collagen turnover, and a history of Achilles
tendon rupture [31,32,33,34]. One long-term goal of our lab is to
identify biomarkers for monitoring disease progression of work-
related musculoskeletal disorders, and for appropriate targeting of
treatments [35,36]. This is especially significant since fibrotic tissue
changes, once present, are difficult to treat [37,38,39,40].
However, neither TGFB1 nor CTGF have been examined in
serum in association with work-related musculoskeletal disorders.
Since CTGF is normally low or undetectable in sera of healthy
individuals, it may serve as a predictive biomarker for patients in
the fibrotic stage of work-related musculoskeletal disorders.
We have developed a rat model of voluntary reaching and
grasping, in which reach rates and force levels were determined
from epidemiological studies for risk exposure in humans [41]. We
have observed exposure-dependent (level of task and time of
exposure) motor declines. Performance of a high repetition low
force, food retrieval, task for 8 weeks induced inflammatory
cytokine increases and grip strength declines, while performance of
a low repetition low force task did not [42,43,44,45]. A follow up
study in rats performing a high repetition low force (HRLF),
handle-pulling, task for 12 weeks showed persistent grip strength
declines despite resolution of an earlier pro-inflammatory cytokine
response in serum [46]. In recent studies examining the effects of
performance of a high repetition high force, handle-pulling, task
for 6–12 weeks, we observed increased production of TGFB1 and
CTGF in forelimb nerves, muscles and tendons [47,48]. A two-
week treatment of HRHF rats treated in weeks 5–6 of task
exposure with ibuprofen or anti-TNF-a attenuated increased
inflammatory cytokines, CTGF and fibrosis in forelimb muscles,
and grip strength declines [47,49]. From these results, we
hypothesize that both pro-inflammatory responses and fibrotic
responses contribute to motor declines, although their temporal
pattern of expression may differ, with acute inflammatory
responses appearing early and fibrotic responses appearing later
with prolonged task performance. However, we have not
examined the effects of performing repetitive tasks beyond 12
weeks in this model; this is necessary in order to parse out which
mechanism, inflammation or fibrosis (or both), is contributing to
persistent motor declines.
In this study, we extended our past shorter-term studies of 12
weeks or less, to examine the effects of performing the high
repetition low force (HRLF), handle-pulling, task for 18 to 24
weeks on forearm grip strength, and on inflammatory, fibrotic or
degradative responses in forearm muscle and tendons. We
hypothesize that acute inflammatory responses contribute to early
declines in grip strength and that fibrogenic tissue responses
contribute to chronic grip strength declines. We also sought to
identify serum biomarkers indicative of underlying tissue process-
es, hypothesizing that at least one serum biomarker of each process
would be detectable in serum. To meet these goals, we assessed the
following in young adult rats performing a HRLF handle-pulling
task for 18–24 weeks: 1) forearm grip strength; 2) flexor digitorum
muscles and tendons for mediators of inflammation, fibrosis and
degradative changes; and 3) serum for similar protein analytes.
Adult female rats were used for several reasons: (1) Human
females have a higher incidence of work-related musculoskeletal
disorders than males [50]; (2) for comparison to data from our
many past studies on female rats; (3) these rats were part of other
studies examining the other tissues, such as bone and brains, that
required use of female rats for consistency.
Methods
Subjects
The Temple University Institutional Animal Care and Use
Committee approved all experiments in compliance with NIH
guidelines for the care and use of laboratory animals. Seventy-nine
total young adult, female Sprague-Dawley rats (3 mo. of age at
onset of experiments) were used. As shown in Figure 1, rats were
randomly divided into one of 5 groups: age-matched normal
controls (NC); age- and weight-matched food restricted controls
(FRC), age-matched trained-only rats that underwent the initial
training, and that were then either euthanized after the training
period (TR0), or rested for 24 weeks before euthanasia (TR24;
TR+REST); and rats that were also trained to learn the task, and
then performed the high repetition low force task (HRLF) task for
18 or 24 weeks before euthanasia (numbers/group are shown in
Figure 1). Rats were housed in a central animal facility in separate
cages with a 12-hour light: dark cycle and free access to water.
Rats were weighed weekly and their food was adjusted to maintain
695% body weight of age-matched controls in order to avoid
catabolic tissue changes that might occur with greater weight loss,
and to avoid confounds of obesity (the rats tend to work hard for
the banana-flavored food pellets used as part of the reward for
successful task performance). All rats were inspected weekly and
again post-mortem for presence of illness or tumors in order to
reduce confounders for serum cytokine increases (none were
observed). To further reduce illness related confounders, addi-
tional sentinel rats were examined for presence of viral infections
or other illnesses as part of the regular veterinary care (none were
detected).
Training Period
Prior to the initiation of the experiments, all rats were handled
for 10 minutes/day for 2 weeks. All but normal control rats were
randomly selected and food-restricted for a short period (no more
than 7 days) by 5–15% of their naive weight (i.e., they lost no more
than 5–15% of naive body weight) to initiate interest in the food
pellets (Fig. 2A). After that first week of food restriction, all food-
restricted rats were given extra food chow and then maintained
thereafter as closely as possible to within 5% of their naive weight
until euthanasia (Fig. 2A). It is our experience that female rats
require little food restriction for motivation after they have learned
Persistent Inflammation and Fibrosis with Overuse
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the task. Fourteen of the food-restricted rats did not proceed to
training, and served as FRC rats (randomly selected; Fig. 1). Fifty
more of the food-restricted rats went through an initial training
period of 10–15 minutes/day, 5 days/week, for approximately 4
weeks, in which they were trained to perform the reaching and
handle pulling task at a high repetition low force level. During this
period, the rats moved through several stages of training. First,
they were placed in an operant behavior box with a portal
modified with an attached trough, and introduced to a 1:1 mix of
grain-based and banana-flavored pellets that served as food
reward (Bioserve, Frenchtown, NJ). When they learned to reach
(without a specified reach rate) into a trough for the food pellets, a
time period of typically 3–7 days, they were moved to the custom-
designed operant conditioning chambers, described in detail
previously [51], and as depicted previously [48]. In the chambers,
rats learned with the aid of auditory and light cueing to reach
through the portal, grasp the force handle, and exert an isometric
pull on the force handle of at first approximately 1% and then 5%
of their maximum voluntary force (the latter equal to 0.10
Newtons) without any specified repetition rate (1–2 weeks), and
then at 0.23 Newton (15% of their maximum voluntary force,
making this a low force task) without any specified repetition rate
(another 1–2 weeks). By the end of this 4 week training period, the
rats were able to perform the HRLF task of four reaches/min at
15% of their maximum voluntary force. A subset of these rats were
randomly selected to serve as trained only rats (n = 26; Fig. 1), and
did not proceed to HRLF task performance. Fourteen of these TR
only rats were euthanized immediately after training in order to
determine the immediate effects of training (TR0); twelve more
rested for 24 weeks before euthanasia (TR24), while receiving a
diet similar to the HRLF rats, in order to serve as age-matched,
diet-matched training controls.
HRLF Repetitive Task Regimen
Following the training period, subsets of trained rats were
randomly chosen from the trained groups to become HRLF rats
(n = 24; Fig. 1). The HRLF rats reached and pulled a handle at a
rate of 4 reaches/minute at 1565% of maximum voluntary force,
for 2 hours/day in 30 minute sessions, for 3 days/week, for up to
24 weeks.. The task was divided into four, 0.5-hour sessions
separated by 1.5 hour in order to avoid satiation. Because the
inherent nature of our task is voluntary, the rats tended to over-
reach, maintaining an average 5.0460.45 successful reaches/
minute rather than the target rate of four reaches/minute. In
addition, they were not prevented from reaching at a higher or
lower force than the target of 0.23 Newtons (15% of maximum
pulling force). However, a food reward was not given unless they
met the force criterion within a 5 sec window initiated every
15 sec. Limb dominance was not evident until after the training
period, but was evident during the task regimen, and was
recording thereafter. Rats were allowed to use their preferred
limb to reach (the ‘‘reach’’ limb), and their contralateral limb as
support against the operant chamber wall while pulling (the
‘‘support’’ limb), as described and depicted previously [48]. Thus,
the animals were allowed to self-regulate their participation in task
performance, making this an operant, voluntary task.
Motor function assay
Grip strength was measured in all animals bilaterally at baseline,
after training, and every 3 weeks thereafter, using a rat grip
strength recording unit (Stoelting, Wood Dale, IL), as described
previously [51], by an examiner naı¨ve to group assignment
(CKW). The test was repeated 3–5 times/limb/trial, and
maximum grip strength per trial is reported.
Serum assays
Following euthanasia (Nembutal, 120 mg/kg body weight),
36 hours after completion of the final task session, blood was
collected from all rats by cardiac puncture using a 23-gauge needle
and centrifuged immediately at 1000 g for 20 min at 4uC. Serum
was collected and stored at 280uC until analyzed, and then
assessed for 13 analytes in 8–15/group, as shown in Figure 1.
Using customized multiplex ELISA plates (Aushon Biosystems,
Billerica, MA), serum was assessed for: interleukin (IL)-1a, IL-1b,
IL-2, IL-4, IL-6, IL-10, macrophage inflammatory protein (MIP) 2
and MIP3; matrix metalloproteinase 2 (MMP2), platelet derived
growth factor ab and bb (PDGFab and PDGFbb), and tumor
Figure 1. Design of experiment. All rats were handled daily for week 1. Then, all but normal control rats (NC) were food restricted to within 5% of
the weights of the NC rats for the remainder of the experiments. Food restricted control rats (FRC) did not undergo training and did not perform the
high repetition low force (HRLF) task. A cohort of rats were trained only for 4 weeks, and then euthanized (TR0). Another cohort was trained only for 4
weeks, and then rested for 24 weeks (TR24). Two groups of rats performed the HRLF task for either 18 weeks or 24 weeks (18-week HRLF and 24-week
HRLF rats). After euthanasia, serum (S) was collected from all rats and assayed in nearly all rats. Half of the tissues were analyzed using biochemical
methods (B) or histological methods (H).
doi:10.1371/journal.pone.0071875.g001
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necrosis factor-alpha (TNF-a). Serum was also tested using single-
plex ELISA kits for CTGF, IL-12, PINP (N-terminal propeptide
type I procollagen), hydroxyproline, TGFB1 (kits sources were: rat
CTGF from Bio Medical Assay, Beijing, China, #22202; IL-12
from Invitrogen, Grand Island, NY, # KRC0121; rat/mouse
PINP from immunodiagnostics systems, Scottsdale, AZ,
#AC33F1; Hydroxyproline Assay Kit, MAK008, Sigma-Aldrich,
Saint Louis, MO; and rat TGFB1 from Aushon Biosystems). All
serum samples were analyzed in duplicate, according to manu-
facturer’s directions, and presented as pg/ml or micrograms/ml of
serum.
Tissue biochemical assays
Following euthanasia and serum collection, rats were divided
into two approximately equal subgroups, one for biochemical
analysis of the flexor digitorum muscle and tendons (5–8/group)
and another group for histological and immunohistochemical
analysis (n = 5–9/group), as shown in Figure 1. The muscle and
tendons for biochemical assay were collected from the distal
forearm region, bilaterally (preferred reach and support limb
tissues were collected), as previously described [48], and flash
frozen in liquid nitrogen. For each tissue type, the outer and inner
connective tissue sheaths were collected with the internal
myofibers or endotendon regions included for muscle and tendons,
respectively. These tissues were homogenized in RIPA buffer using
previously described methods [42]. Supernatants of the tissue
Figure 2. Weight and grip strength changes across weeks of task performance. (A) All rats gained weight across the 29 weeks. There were
no significant differences in body weights between trained only (TR0 and TR24) or high repetition low force (HRLF) rats, compared to normal controls
(NC) rats. (B) Maximum reflexive grip strength is shown for control rats (normal and food-restricted controls were combined as there were no
significant differences between these groups), TR24 (TR+Rest; trained rats that rested after training for 24 weeks), and HRLF rats. The preferred reach
limbs and the contralateral support limbs were analyzed separately in HRLF rats. The week 0 time point of each group is after the training period and
before the HRLF task performance or the rest period. Symbols: *:p,0.05 and ***:p,0.001, compared to age-matched control rats; aa: p,0.01 and
aaa:p,0.001, compared to age-matched TR24 rats; b: p,0.05, compared to the support limb of HRLF rats.
doi:10.1371/journal.pone.0071875.g002
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homogenates were stored at 280uC, until assayed using ELISA
kits and manufacturers’ instructions for 11 analytes: IL-1a, IL-1b,
IL-6, IL-10, IL-12, MIP2 and TNF-a using single ELISA kits,
(each from Invitrogen), and for CTGF, TGFB1, PDGFab,
PDGFbb, hydroxyproline, and MMP2, using the same ELISA
kits as for serum assays (serum and tissues were batched assayed
with kits from Bio Medical Assay or Aushon Biosystems). Each
sample was run in duplicate. ELISA assay data (pg cytokine
protein) were normalized to mg of total protein, determined using a
bicinchoninic acid protein assay kit (Thermo Scientific, Pierce,
Rockland, IL, #23225).
In addition to the ELISA assays, subsets of samples (n = 3–4/
group) were examined using western blot or gelatin zymogram
methods. TGFB1 Western blots were performed on supernatants
from homogenized flexor digitorum muscles from NC (n = 4), TR0
(n = 4), 18-week HRLF (n = 4), and 24-week HRLF (n = 3) rats.
100 mg of protein was loaded per lane, with reducing agent, on
NuPage Novex Bis-Tris mini gels. Anti-rat TGFB1 antibody was
used (1:2000; Santa Cruz Biotechnology, Inc., Dallas, TX, #sc-
146), followed by probing with a secondary antibody tagged with
IRDye800CW (1:10,000; Li-Cor, #.926-32211), and then Li-Cor
Odyssey Infrared Imaging System. Blots were also probed with
GAPDH (1:2000; glyceraldehyde-3-phosphate dehydrogenase;
Invitrogen, #AM4300), and a secondary antibody tagged
IRDye680LT (1:10,000; Li-Cor, #926-68020), for use as a
loading control. Western blots were repeated three times.
Gelatin zymogram gels were used to examine MMP2 and
MMP9 presence and activity in homogenized flexor digitorum
muscles from NC (n = 4) and 24-week HRLF (n = 3) rats.
Supernatants of muscle homogenates were purified with gelatin
Sepharose 4B beads (GE Healthcare Life Science, Pittsburgh, PA,
#17-0956-01) by adding 500 mg total protein lysate (in 200 ml
PBS) to 25 ml of a 50% slurry of washed gelatin Sepharose 4B
beads in PBS, and incubating them on a shaker for 2 hr at 4uC.
Beads were centrifuged at 2000 rpm for 1 min in a microfuge and
washed with PBS; PBS was aspirated off with a small bore needle.
Beads were resuspended in 25 ml of 26 load buffer, warmed to
50uC for 5 min, and 20 ml loaded per lane onto 10% zymogram
gels (Novex, Life Technologies, #EC61752BOX) using manufac-
turer’s instructions. Purified recombinant rat MMP9 and homog-
enized mouse spleen (gifts from Janssen R&D, Springhouse, PA)
were used as positive controls. Gels were washed with 16
renaturing buffer, then stained with SimplyBlue Safe Stain (Life
Technologies, Grand Island, NY, #LC6060), and imaged with an
ImageQuant LAS 4000 (GE Healthcare Life Science). The
location of gelatinolytic activity was detectable as a clear band
against a background of uniform staining.
Immunohistochemical Analyses
The remaining animals were used for immunohistochemical
analysis to localize protein expression within the tissues of 5–9/
group, as shown in Figure 1. Following euthanasia and after serum
collection, animals were perfused transcardially with 4% buffered
paraformaldehyde. Forearm musculotendinous tissues were col-
lected en bloc (i.e. endotendon with attached epitendon, and
myofibers with attached epimyseum) and sectioned longitudinally,
as described and depicted previously [43,48]. Sections were
immunostained for CTGF and TGFB1 (anti-CTGF, 1:400
dilution in PBS; anti-TGFB1, 1:300), using previously described
methods [47]. Western blot analysis was used to determine
antibody specificity of the TGFB1 antibody; the specificity of the
CTGF antibody used was published previously [47]. Negative
control staining was also performed by omission of either primary
or secondary antibodies, and by using tissues from normal control
rats. Further negative control staining was performed by replacing
the primary antibodies with an isotype matched IgG antibody,
followed by the secondary antibody, in order to assay for any non-
specific binding of the secondary antibodies (none were observed).
Tendon Histopathology
A series of adjacent sections from above were stained with
hematoxylin and eosin (H&E), dehydrated and coverslipped with
DPX mounting medium. These sections, as well as the CTGF-
immunostained sections, were examined for histopathological
changes in tendons of NC (n = 5), TR24 (n = 5), 18-week HRLF
rats (n = 5 each), and 24-week HRLF rats (n = 4). Both
endotendon and epitendon regions of the flexor digitorum tendons
were assessed for histopathological changes using a modification of
the semi-quantitative Bonar scale method. We assessed only 3
factors, each on a 4 point (0–3) scale: cell shape, collagen
organization, and vascularization, using previously described
methods [48,52]. Each of these determinations was made in the
flexor digitorum tendons in the distal forearm to the wrist, in 3
microscope fields/section, and in 3 separate sections/rat, by one
person naı¨ve to group assignment (HG). We then used a
computerized quantification system (Bioquant Osteo II) to
quantify the epitendon thickness in the H&E stained sections
(using the length array option of the system), and epitendon
cellularity in the CTGF stained slides, by counting the number of
CTGF-immunopositive cells per area (mm2), using previously
described methods [53]. Again, these determinations were made in
the flexor digitorum tendons in the distal forearm to the wrist, in 3
microscope fields/section, and in 3 separate sections/rat, by one
person naı¨ve to group assignment (MFB).
Statistical Analyses
All data are expressed as mean 6 SEM. Weight was analyzed
using 2 way ANOVAs with the factors group and week, grip
strength with the factors week and limb, and biochemical assays
for inflammatory cytokines with the factors group and limb. Most
other biochemical assays used one-way ANOVAs with group as
the factor. In each statistical analysis, the Bonferroni method for
correcting for multiple comparisons was used for the post-hoc
analyses. Two-tailed t-tests were used to compare CTGF ELISA
results (TR24 versus 18 week HRLF). For all analyses, adjusted p
values are reported, and after adjustment, p values of ,0.05 were
considered significant. Pearson’s correlation analyses were used to
determine if grip strength values correlated with serum or tissue
inflammatory cytokine levels, and if serum cytokines levels
correlated with tissue cytokines levels; except for CTGF in which
only n = 4 per group were tested and therefore, a Spearman’s rank
correlation test was used instead.
Results
For all data, no differences were found between normal control
(NC) and food restricted (FRC) rats; therefore, data from both
groups were combined into a single control (C) group. Post hoc test
results are shown in the figures for succinctness.
Rat weights – all rats gained weight across the weeks
All rats gained body weight across the weeks of task
performance (2 way ANOVA: Week: p,0.0001), which was
important, since they were young adult rats at the onset of these
experiments (Fig. 2A). The trained only rats (TR0 and TR24,
which were the TR+Rest) rats did not have significantly lower
body weights than the normal control (NC) or HRLF rats, nor did
the HRLF rats have significantly lower body weights than the
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PLOS ONE | www.plosone.org 5 August 2013 | Volume 8 | Issue 8 | e71875
normal control (NC) rats. The food restricted control rats had
similar body weights as the trained only and HRLF rats (data not
shown).
Grip Strength declined progressively in the HRLF reach
limb, but recovered in the support limb
Forearm grip strength was significantly reduced, bilaterally, in
trained and HRLF rats after the initial training period, compared
to control rats (Fig. 2B; 2 way ANOVA: Group p,0.0001, Week:
p,0.0001, Interaction p = 0.004; see figure for post hoc results).
These declines persisted throughout this study and even worsened
in preferred reach limbs of HRLF rats in weeks 18 and 24,
compared to age-matched controls and TR24 (TR+Rest) rats. In
contrast, grip strength declines present after training recovered to
control levels in TR24 (TR+Rest) rats that rested for 24 weeks. A
partial recovery was observed for grip in the contralateral support
limb by week 18, compared to NC, and showed improvement,
compared to preferred reach limbs of these same HRLF rats in
week 24 (Fig. 2B).
A mix of transient, cyclical and late-appearing
inflammatory cytokines in musculotendinous tissues
Since we have previously shown that grip strength declines
correlate with increased muscle and tendon cytokines in rats
performing a similar task for 8 weeks [44], we next examined
flexor digitorum muscles and tendons, bilaterally, for inflamma-
tory cytokines using ELISA (Fig. 3).
In the preferred reach limb, we found low-grade but significant
increases in several pro- and anti-inflammatory cytokines in both
tissue types after training and prolonged HRLF task performance,
although greater increases were observed in tendons than in
muscles, and greater in reach limbs than in the support limbs
(Fig. 3). IL-1b was not increased in reach limb muscles with
training or task performance (Fig. 3A). However, IL-1b was
increased in reach limb tendons after training (TR0 time point)
(Fig. 3B), compared to control (C) rats, and in 18-week HRLF
reach limb tendons, compared to TR24 rats (Fig. 3B). TNF-a was
increased after training, in reach limb muscles and tendons,
resolved by week 18, but increased again in 24-week HRLF reach
limb tissues, compared to C rats; and in 24-week HRLF reach
limb muscles, compared to TR24 rats (Fig. 3C,D). IL-6 was
increased in 24-week HRLF reach limb muscles, compared to C
and TR24 rats, and compared to the support limb (Fig. 3E). IL-6
was also increased in reach limb tendons after training, but
increased further in 24-week HRLF tendons, compared to C rats
and TR24 rats (Fig. 3F). IL-10 was increased only in 24-week
HRLF reach limb muscles, compared to TR24 rat muscles
(Fig. 3G). Additionally, IL-1a was increased in reach limb muscles
of 18-week HRLF rats (1.2560.57, mean6 SEM), compared to C
rats (0.1260.03; p,0.01), and in reach limb tendons of 18-week
HRLF rats (2.2960.69), compared to C rats (0.3060.04; p,0.01)
(data not shown). No increases were seen for IL-12 or MIP2 in any
group or tissue, compared to C rats (data not shown).
In the support limb, fewer changes were seen than in the reach
limb tissues (Fig. 3). No increase in IL-1b was seen in support limb
muscles (Fig. 3A). IL-1b was increased significantly in support limb
tendons after training (TR0 time point), compared to control (C)
rats (Fig. 3B), but resolved thereafter. TNF-a was increased after
training in the support limb muscles and tendons, but showed
resolution by week 18 (Fig. 3C,D). IL-6 was increased in 24-week
HRLF support limb muscles, compared to TR24 rats, but showed
no increase compared to control rats, and was lower than in reach
limb muscles (Fig. 3E). IL-6 was also increased in support limb
tendons after training, showed resolution by week 18, but
increased again in 24-week HRLF rats, compared to C rats and
TR24 rats (Fig. 3F). IL-10 was not increased in support limb
tissues (Fig. 3G,F), nor was IL-1a (data not shown).
Increased pro- and anti-inflammatory cytokines in serum
with prolonged HRLF task performance
We next examined serum for these same and related cytokines
to determine if there were concomitant increases in serum as in
tissues. TNF-a and IL-6 were increased in serum of 24-week
HRLF rats, compared to C rats (ANOVA results were p = 0.02
and 0.001, respectively; Fig. 4A,B). IL-6 was also higher in 24-
week HRLF rats, compared to TR24 rats (Fig. 4B). IL-10, IL-1a
and IL-12 were increased in serum of 18-week HRLF rats,
compared to C rats (ANOVA results were p = 0.03, 0.03 and 0.02,
respectively; Fig. 4C–E). Serum MIP2 levels trended higher in 18-
week HRLF compared to C rats, but did not reach significance
(ANOVA: p = 0.07; Fig. 4F). No serum increases were seen for IL-
1b, IL-2, IL-4 or MIP3 (data not shown). There were also
increases of TNF-a, IL-10, and IL-1a in the serum of TR0 rats,
although there was high variability (and thus no significant
increase).
Increased fibrogenic proteins in serum and
musculotendinous tissues with long-term task
performance
Since IL-6 and TNF-a are not only pro-inflammatory cytokines,
but also pro-fibrogenic cytokines, we next extended our study to
examine for increases of four other fibrogenic cytokines: TGFB1,
CTGF, and PDGFab and PDGFbb (Figures 5–7). We focused on
the reach limb tissues, since they showed consistent significant grip
strength declines and inflammatory cytokine increases, from
control levels.
TGFB1 was increased in both serum and reach limb tendons
(entire distal tendon, including epi- and endotendon) of 18-week
HRLF rats, compared to C rats (ANOVA: p = 0.03 and 0.003,
respectively; Fig. 5A,B), as assayed using ELISA. Immunohisto-
chemistry was used to localize TGFB1 expression in the reach
limb tendons and showed a few TGFB1-immunoreactive fibro-
blast-like cells in the peritendon, as well as TGFB1-immunoreac-
tive tenocytes in the endotendons NC rats (Fig. 5C, middle panel),
but more TGFB1-immunoreactive cells in the epitendon region of
18- and 24-week HRLF rat tendons, in fibroblast-like cells (Fig. 5C
right panel; 24-week data not shown). The tenocytes in the
endotendon region of 28-week HRLF rats appeared more
TGFB1-immunorective, but were not increased in number.
Western blot analysis of reach limb muscle showed that the
50 kDa subunit (the precursor form) of TGFB1 protein increased
in reach limb muscles of 24-week HRLF rats, compared to both C
and TR24 rats (ANOVA: p = 0.002; Fig. 5D,F), although the
12.5 kDa subunit of TGFB1 (the active form) did not increase
(Fig. 5E,F).
CTGF was increased in serum and reach limb flexor digitorum
muscles of 24-week HRLF rats, compared to C rats (ANOVA:
p = 0.03, each; Fig. 6A,B), as assayed using ELISA. Immunohis-
tochemistry was then used to localize CTGF expression and
showed a qualitative increase of CTGF immunopositive fibroblast-
like cells in the epitendon, and in tenocytes in the endotendon 18
and 24 week HRLF reach limb tendons, compared to control (C)
rats (Figure 6C,D. The 24-week HRLF data is not shown, but
looked similar to 18-week HRLF tendons.
Both quantitative and semi-quantitative image analyses were
performed on reach limb tendons. Quantitative image analysis
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showed increased thickness of the epitendon of reach limb tendons
in 18- and 24-week HRLF rats, compared to Control (C) rats
(ANOVA: p,0.0001; Fig. 6E), and increased numbers of CTGF-
immunopositive cells in the epitendon of 18- and 24-week HRLF
rats, compared to Control (C) rats (ANOVA: p = 0.0006; Fig. 6F),
each indicative of epitendon hyperplasia. We also assayed the
reach limb endotendon using a semi-quantitative Bonar scoring
system of tendon pathology, and observed a small but significant
change in tenocyte shape in 18-week HRLF rats, compared to
TR0 rats (ANOVA: p = 0.001; Fig. 6G). They were still slender,
but were thicker and more elongated than in control rat
endotendons (See Figure 5C right panel and Figure 6D). No
evidence of collagen disorganization was seen in the reach limb
endotendon of 18-week HRLF rats, compared to TR24 or TR0
Figure 3. Pro- and anti-inflammatory cytokines in forelimb flexor digitorum tissues. Data shown for cytokines assayed in muscles and
tendons after collection from control rats (indicated as C; normal and food restricted control data was combined as there was no significant
difference), trained only rats euthanized immediately after training ( indicated as TR0 on the x-axes), TR+Rest (TR24; trained rats that rested for 24
weeks; blue dashed lines), and high repetition low force (HRLF) rats that worked for 18 or 24 weeks of task performance before tissue collection. The
preferred reach limbs (red line) and the contralateral support limbs (green lines) were examined separately in HRLF rats. (A & B) Muscle and Tendon
IL-1beta. (C & D) Muscle and Tendon TNF-alpha. (E & F) Muscle and Tendon IL-6. (G & H) Muscle and Tendon IL-10. Each analyte was assayed in
duplicate using single-plex ELISA kits. Symbols: *:p,0.05, **:p,0.01 and ***:p,0.001, compared to age-matched control rats; a: p,0.05 and
aa:p,0.01, compared to age-matched TR+Rest rats; b: p,0.05, compared to the support limb of HRLF rats.
doi:10.1371/journal.pone.0071875.g003
Figure 4. Pro- and anti-inflammatory cytokines in serum. Groups are as defined in figure legend 2. Data is shown for (A) TNF-alpha, (B) IL-6, (C)
IL-10, (D), IL-1alpha, (E) IL-12 (only TR24 and 18 wk HRLF rat serum were tested for IL-12), and (F) MIP2. Symbols: *:p,0.05, **:p,0.01, compared to
age-matched control rats. a: p,0.05, compared to age-matched trained rats that rested for 24 weeks after the initial training period.
doi:10.1371/journal.pone.0071875.g004
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Figure 5. Transforming growth factor beta 1 (TGFB1) in serum and flexor digitorum tissues of the reach limbs. Groups are as defined in
figure legend 2. (A&B) Serum TGFB1 and tendon TGFB1, assayed using ELISA. (C) Immunohistochemical staining for TGFB1 in tendons from NC and
18-week HRLF reach limbs shows localization of TGFB1 in fibroblast-like cells in the peritendon region of both the NC and HRLF rats, and additional
stained cells in the epitendon (Epi; thickened in HRLF rats) and endotendon (T) regions of the HRLF rat tendon. (D&E) The results of Western blot
analysis of muscle TGFB1 in which two bands were detected, 50 kDa and 12.5 kDa. The ratio of each band of TGFB1 normalized to GAPDH levels is
shown for three replicates of the western blot. (F) A representative Western blot of reach limb muscles from normal controls (NC, n = 4 shown), 24-
week HRLF rats (n = 3 shown), and 18-week HRLF rats (n = 4 shown), probed with anti-TGFB1 and GAPDH. Green bands were detected with an anti-
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rats (ANOVA: p = n.s.; Fig. 6H). Assessment of the support limb
tendons of 18-week and 24-week HRLF rats using the full Bonar
scoring showed no significant changes from control rat histomor-
phometry (data not shown).
There was an increase in serum levels of PDGFab and PDGFbb
in 18-week HRLF rats, compared to C rats (ANOVA: p = 0.0008
and p,0.0001, respectively; Fig. 7A,B). However, flexor digitorum
tendons (reach limb only examined) showed no increase of either
using ELISA (Fig. 7C,D), indicating that they were not the source
of serum PDGF. We also sought to determine if there were
changes in serum levels of a collagen synthesis marker (PINP) or a
collagen turnover (hydroxyproline) as a result of task performance.
PINP was not significantly increased in serum of any trained or
HRLF rats, compared to control (C) rats (data not shown). In
contrast, hydroxyproline levels were increased significantly in both
serum and reach limb muscle tissues of 18-week HRLF rats,
compared to controls (ANOVA: p = 0.03 and p = 0.01, respec-
tively; Fig. 7E,F).
Increased collagenolytic gelatinase, MMP2, in HRLF
serum and tendons
The collagen degradation marker, MMP2, increased in serum
of 18- and 24-week HRLF rats, compared to control (C) and TR0
rats (ANOVA: p = 0.04; Fig. 8A), and in reach limb tendons of 18-
week HRLF rat weeks, compared to C rats (ANOVA: p = 0.04;
Fig. 8B), each assayed using ELISA. The 24-week HRLF rat
tendons from reach limb were not assayed for MMP2 due to
insufficient quantities of tendon tissues. Gelatin zymography
demonstrated that muscle homogenates of NC rats had low levels
of active MMP2 (62 kDa subunit) but no increase of pro-MMP2
(72 kDa subunit). The 24-week HRLF rats had increases of both
pro-MMP2 and active MMP2 in their reach limb muscles
(Fig. 8C). No MMP9 was detected in the muscles, compared to
mouse spleen homogenate (Fig. 8C) or purified recombinant rat
MMP9 (not shown).
Correlations between grip strength and cytokines/MMP2,
and between serum and tissue analytes
As shown in Table 1, grip strength declines in the reach limbs
correlated with increased IL-6, TNF-a and TGFB1 in flexor
digitorum muscle from these same limbs; increased IL-6, TGFB1
and MMP2 in flexor digitorum tendons from these same limbs;
and increased numbers of CTGF-immunopositive cells in the
tendons from these same limbs. Grip strength declines also
correlated significantly with increased serum IL-6, TNF-a,
TGFB1 and MMP2, and showed a strong correlating trend with
serum CTGF (p = 0.05). Increased serum IL-6, TNF-a, TGFB1,
CTGF and MMP2 also correlated with increases of these same
analytes in the tissues (Table 1).
Discussion
We hypothesized that grip strength declines would be associated
with forearm musculotendinous inflammatory and fibrotic changes
with long-term overuse activity at a moderate task level. We
observed persistent and progressive declines in forearm grip
strength in reach limbs of HRLF rats, but complete recovery with
rest in TR24 rats, and a partial recovery in the support limbs.
Persistent low-grade increases of inflammatory cytokines were
observed in flexor digitorum tissues after the initial training period
and throughout task performance, with higher responses in the
tendons than in the muscles, and significantly higher responses in
the reach limb tissues than in the support limb tissues. The
cytokine profile varied, dependent on tissue type, time of task
performance, and cytokine type (with, for example, a key anti-
inflammatory cytokine, IL-10, increased only in 24-week HRLF
rats, but pro-inflammatory cytokines showing earlier and more
cyclical type responses). Two fibrogenic proteins (TGFB1 and
CTGF) and a collagenolytic protein (MMP2) increased in reach
limb muscles and/or tendons of 18- and 24-week HRLF rats,
temporally matching epitendon fibrosis in the reach limb. Our
hypothesis was supported in that grip strength of the reach limbs
correlated inversely with flexor digitorum tissue levels of IL-6,
TNF-a, TGFB1, CTGF and MMP2 from these same limbs. We
also sought to identify serum biomarkers indicative of underlying
tissue processes, and hypothesized that at least one serum
biomarker of each process would be increased. Serum levels of
TNF-a and IL-6 temporally matched and correlated with tissue
increases. We also shown here for the first time that four fibrogenic
proteins, TGFB1, CTGF, PDGFab and PDGFbb, hydroxypro-
line, as well as MMP2, a degradative collagenase, increased in
serum with performance a HRLF task for weeks 18 or 24,
concomitant with peritendon hyperplasia, increased tissue
TGFB1, CTGF, hydroxyproline, and MMP2. Lastly, grip strength
correlated inversely with serum levels of IL-6, TNF-a, TGFB1 and
MMP2, and showed a strong trend towards correlating with serum
CTGF levels.
This is our first study examining grip strength declines in rats
performing repetitive tasks for more than 12 weeks. The data
demonstrate that there are significant effects of training on grip
strength in the reach limbs that persisted and worsened in rats that
continued to perform the HRLF task for 24 weeks. In a recent
study, declines in grip strength were also present, in the reach
limbs, immediately after training in rats that had just learned a
high force task, but not a negligible force task, indicating an
exposure dependent effect of training on grip strength [47].
Apparently, training for 10 min/day, 5 days/week, for 4–6 weeks
to learn moderate (e.g. this HRLF task) or high force repetitive
tasks impacts grip strength in the preferred reach limbs negatively.
In TR24 (TR+Rest) rats, grip strength declines resolved by 18
weeks of rest, suggestive of tissue healing as a consequence of the
rest. We observed only a partial recovery of grip strength in young
adult TR+Rest rats in a recent 12-week study, in which the trained
only rats rested for only 12 weeks [46]. These findings suggest that
long rest periods are needed for complete recovery of grip strength
after the initial training period.
We also observed declines in grip strength in the contralateral,
support limbs of these HRLF rats after training and through week
18. The declines in the support limb are most likely due to its use
for support against the operant chamber wall during the task, as
previously examined in rats performing a high repetition high
force task for 12 weeks [48]. The declines in grip strength in the
support limbs of rats performing a high repetition high force in our
prior study [48] was considerably more than observed in this
study, in which rats are performing a high repetition low force
task, suggesting that tissues in the high force study were nearing
their threshold for failure [54]. However, in this study examining
the effects of a low force task, the recovery of grip strength in the
TGFB1 antibody and a secondary antibody tagged with IRDye800CW (Li-Cor, #.926-32211). Red bands were detected with an anti-GAPDH antibody
and a secondary antibody tagged IRDye680LT (Li-Cor, #926-68020). Symbols: *:p,0.05, **:p,0.01, compared to age-matched control rats; a: p,0.05,
compared to TR24 rats. Scale bar = 50 micrometers.
doi:10.1371/journal.pone.0071875.g005
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Figure 6. Connective tissue growth factor (CTGF) in serum and flexor digitorum tissues of the reach limbs. Groups are as defined in
figure legend 2. (A) Serum CTGF and (B) muscle CTGF, assayed using ELISA. *:p,0.05, compared to age-matched control rats. (C&D)
Immunohistochemical localization of CTGF in flexor digitorum tendons from control (normal control) and 18-week HRLF rats. Epitendon (Epi) is no
longer distinct from peritendon (peri) regions in this HRLF rat. (E&F) Quantification of epitendon thickness and number of CTGF-immunopositive cells
in the epitendon. *:p,0.05 and **:p,0.01, compared to age-matched control rats. Endot = endotendon. Scale bar = 50 micrometers.
doi:10.1371/journal.pone.0071875.g006
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HRLF support limbs by week 18 is likely due to adaptation of
tissues to the demands of providing support. In contrast, the
persistent and progressive grip strength declines in the reach limbs
of HRLF rats indicate that tissues in that limb are not adapting to
the moderate demands of this repetitive task.
We observed a low-grade, cyclical, tissue inflammatory response
in musculotendinous tissues with performance of this HRLF task
for 24 weeks, extending our past shorter studies of 8 to 12 weeks
examining the effects of this HRLF task and a related high
repetition negligible force (HRNF) task [42,44,47,55]. What we
did not expect, but observed, were differential cytokine responses
in flexor digitorum tissues over time. For example, tendon
responses were greater than those in muscles, and preferred reach
limb tissues were greater than in the support limb tissues. The
specific cytokines examined also varied in their response profiles.
IL-1b, TNF-a and IL-6 increased after training, bilaterally, since
Figure 7. Platelet derived growth factor ab (PDGFab) and PDGF bb in serum and flexor digitorum tendons of the reach limbs, and
hydroxyproline in serum and flexor digitorummuscles of the reach limbs. ELISA data for normal controls have been combined with that of
food restricted controls (C); TR0 (trained only rats), TR21 (trained rats that rested for 21 weeks), and high repetition low force (HRLF) rats that
performed the task for 18 or 24 weeks. ** and *: p,0.05 and p,0.01, compared to C rats; a: p,0.05, compared to TR0 rats.
doi:10.1371/journal.pone.0071875.g007
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the rats tend to not show limb dominance during training. TNF-a
was resolved, bilaterally, by week 18 in HRLF rat tendons and
muscles. IL-6 had resolved only in the support limb by week 18,
also it was still elevated in reach limb tendons of HRLF rats in
week 18, as was but IL-1a and IL-1b. By week 24, TNF-a had
increased again in HRLF reach limb tissues, compared to control
and TR24 (TR+Rest) rats; IL-6 was increased in reach limb
HRLF tissues, compared to control and TR24 rats; and IL-10 was
increased in muscles, compared to TR+Rest rats. The inflamma-
tory cytokine response after the training period is likely due to the
onset of an injury-induced cytokine response [56]. The resolution
of inflammation in TR24 (TR+Rest) rats and in the HRLF
support limbs by week 18 is likely due to tissue repair as a
consequence of rest and adaptation, respectively, as is the partial
resolution in week 18 in the reach limbs. This is supported by our
prior results showing only a transient inflammatory response in
tissues of rats performing lower demand tasks [42,45]. However,
the reappearance of the tissue inflammatory response and the
increased IL-10 (an anti-inflammatory cytokine) in week 24 in the
reach limbs, and partially in the support limbs (IL-6), suggests that
tissue adaptation processes are not keeping pace with tissue injury
or degradative processes. The cyclical inflammatory episodes are
consistent with an overexertion theory of MSD development [57],
which postulates that when tissue exposure level remains below a
critical threshold, inflammatory and repair processes occur that
are successful in resolving tissue disruption and restoring normal
tissue tolerance through healing. When tissue exposure exceeds
this critical threshold, persistent or cyclical inflammatory changes
and incomplete tissue healing results in reduced tissue tolerance
and function [57] (the latter indicated by the reduced grip strength
in this study).
We also observed a serum inflammatory response with
performance of the HRLF task for 18 to 24 weeks, extending
our past shorter studies of 8 to 12 weeks with this task and a related
high repetition negligible force (HRNF) task [42,43,46], with
temporal differences across weeks of task performance. The
variable increase after training indicates that the 10 min/day, 5
days/week, 4–5 week training period in which rats are learning
this moderate level tasks is not enough to induce significant
increases of inflammatory cytokines in blood, matching findings in
prior studies from our lab examining the effects of learning low
force tasks [42,46]. However, continued performance of the
HRLF task induced increased serum MIP2 and interferon gamma
by week 6 [46], a resolution of the serum response by week 12 (to
be specific, no increase of IL-1a, TNF-a, MIP2, IL-6 or IL-10)
[46], but reappearance in weeks 18 (IL-1a and IL-12) and 24
(TNF-a and IL-6) in this current study. The increase of IL-10 in
HRLF week 18 may be one reason for the decline of IL-1a in
HRLF week 24, since IL-10 plays a key role in limiting immune
responses [58]. IL-6 also has anti-inflammatory properties, as
discussed further below. The increase of TNF-a in week 24 may
be due to the increase of IL-12 in week 18, a known inducer of
TNF-a in macrophages [59]. We have shown that macrophages
increase in flexor digitorum tissues with prolonged HRLF task
performance [55].
The serum inflammatory cytokines in patients with upper
extremity MSDs diagnoses (patients with signs and symptoms of
carpal tunnel syndrome, rotator cuff tendinitis, and medial/lateral
epicondylitis) is also varied temporally. In patients with symptoms
of 1 month or less in duration, serum levels of soluble IL-1RII and
IL-18 increase (but not TNF-a, IL-1a, IL-1b or IL-6). In patients
with symptoms of 3 months in duration, serum levels of TNF-a,
IL-1b and IL-6 increase [2]. Although the duration of symptoms
were not reported in a third study, video terminal operators with
mild to moderate functional impairments and localized pain
(indicative of having worked as video terminal operators for at
least long enough to develop mild to moderate work-related
musculoskeletal disorders) have increased serum IL-6 and TNF-a,
compared to healthy controls [4]. The members of the IL-1 family
appear to be functioning more as early onset responders and
biomarkers, with TNF-a and IL-6 as later phase biomarkers of
injury and inflammation.
Figure 8. MMP2 levels in serum and flexor digitorum tendons
and muscles of the reach limbs. Groups are as defined in figure
legend 2. MMP2 levels in (A) serum and (B) flexor digitorum tendons
tested using ELISA. *:p,0.05, compared to C; a: p,0.05, compared to
TR0 rats. (C) Gelatin zymography showing that muscle homogenates of
24-week HRLF rats have increased pro-MMP2 (72 kDa) and active MMP2
(62 kDa) compared to NC rats. Neither group showed any MMP9
activity. The far left lane is the marker (M). The far right lane was loaded
with homogenized mouse spleen, which contains MMP9 and low levels
of active MMP2.
doi:10.1371/journal.pone.0071875.g008
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However, increased IL-6 in tissues and serum is subject to
multiple interpretations. Many forms of exercise can induce
increased tissue and serum inflammatory cytokines, including IL-
6, although these increases are usually rapid in nature [60,61]. In
this study, it is not likely that the observed inflammatory cytokines
increases are exercise-induced, since we waited 36 hours after the
last task session to collect tissues and serum. IL-6 has been
reported to have both pro- and anti-inflammatory actions;
therefore, it may be acting in an anti-inflammatory mode with
IL-10 [20,60], although since it increased in week 24, the end of
our experimental paradigm, we are not able to speculate on that
possible function here. IL-6 is also a fibrotic protein and up-
regulates CTGF production by fibroblasts in vitro [19]. This is of
interest because tissues collected from humans with upper
extremity work-related musculoskeletal disorders show the pres-
ence of fibrosis and its mediators, including IL-6 and TGFB1
[11,23,62]. IL-1b and TNF-a have also been deemed pro-fibrotic,
due to their mitogenic and chemotactic effects on fibroblasts and
induction of TGFB1 [14,15,16,17,18]. We postulate that IL-1b,
TNF-a IL-6 increase at points of tissue injury or worsening tissue
injury (such as after training and then in week 24 after a failed
resolution stage due to continued task performance), and that their
persistent increase is contributing to the later appearing fibrotic
responses.
As stated in the introduction, TGFB1 and CTGF are sensitive
serum biomarkers of fibrogenic diseases [26,30]. This is the first
time, to our knowledge, that serum increases of either have been
linked to work-related musculoskeletal disorders. Several studies
have shown that TGFB1 and CTGF increase in tissues under
conditions of overload or injury [63,64,65]. Increases of TGFB1,
CTGF and IL-6, have been linked to the pathogenesis of tissue
fibrosis [66,67,68,69]. Stauber and colleagues reported elevated
levels of TGF-beta1 precursor proteins in strain-injured skeletal
muscles 48 h after injury [65], although like this study, no increase
in TGFB1 active subunit (12.5 kDa), postulating potential rapid
clearance of the active form from the muscle. CTGF is the
downstream mediator of TGFB1 and is produced by multiple cell
types [70,71,72]. TGFB1-induced CTGF expression leads to
fibroblast proliferation and extracellular matrix deposition [72].
However, CTGF production is also regulated by TNF-a
[47,73,74], which is interesting since we observe increases of each
in reach limb tissues and serum in this study. Furthermore, CTGF
stimulation increases IL6, IL-1 and TNF-a mRNA levels in
human tendon fibroblasts, suggestive of an autocrine/paracrine
feedback loop between these fibrogenic proteins [66]. In our
model, we have previously reported increased CTGF in peripheral
nerves, muscles, and epitendons of involved forearm and shoulder
tendons with prolonged performance of low to high demand
repetitive tasks [47,48,51,55,71]. We recently reported that a two-
week treatment with an anti-rat TNF- a monoclonal antibody
decreased CTGF and collagen extracellular matrix production
(although TGFB1 levels did not alter) [47]. The fibrotic changes
observed in this current study were mild, with no increase in serum
PINP, modest increases of CTGF in serum and reach limb
muscles and tendons, although significant increases of hydroxy-
proline in both serum and reach limb muscles. The latter is
suggestive of collagen accumulation in tissues, and has been shown
to increase in fibrotic diaphragm muscles of the mdx mouse, a
model for Duchenne dystrophy [89]. Increased serum hydroxy-
proline has been indicated as a biochemical predictor of liver
fibrosis, especially when combined with other serum biomarkers of
collagen accumulation and turnover [90,91] that we are observing
the onset of fibrosis in these 18-week HRLF rats
It has been suggested that inhibition of CTGF activity could be
a suitable target for prevention of fibrotic disorders [75,76]. In this
study we have demonstrated significant up-regulation of CTGF
expression that correlates with the fibrotic changes observed in the
HFLF model, but we have not established a causal relationship
these two findings. Additional studies are underway to determine
whether elevated CTGF is an essential mediator of these fibrotic
events. If so, then one could envision CTGF as a potential
therapeutic target to prevent the fibrosis and reduced function that
occurs as a consequence of overuse.
We also observed an increase in two subtypes of PDGF. PDGF
is a repair cytokine synthesized by numerous cell types, including
platelets, macrophages, fibroblasts and osteoblasts, and known to
promote skeletogenesis, organogenesis, angiogenesis and wound
healing [77–79]. While it is clear that PDGF subtypes are not
Table 1. Significant Pearson’s and Spearman’s* Correlations.
Correlations with Grip Strength in reach limbs with muscle and tendon findings from same limbs
FD Muscle FD Tendon Serum
IL6 r =20.49, p = 0.0004 r =20.44, p = 0.0013 r =20.30, p = 0.03
TNF-a r =20.32, p = 0.049 n.s. r =20.56, p = 0.0001
TGFB1 r =20.59, p = 0.004 r =20.71, p = 0.002 r =20.59, p = 0.004
CTGF n.s.* r =20.73, p = 0.0001#f r =20.50, n.s.
MMP2 n.t. r =20.62, p = 0.009 r =20.49, p = 0.001
Correlations between serum and tissue analyte levels
FD Muscle FD Tendon
Serum IL-6 IL-6: r = 0.36, p = 0.03 IL-6: r = 0.55, p = 0.0004
Serum TNF-a TNF-a: r = 0.54, p = 0.0005 TNF-a: r = 0.28, p = 0.04
Serum TGFB1 TGFB1: ns TGFB1: r = 0.65, p = 0.006
Serum CTGF CTGF: r = 0.71*, p = 0.04 CTGF#f: r = 0.75, p = 0.03
Serum MMP2 MMP2: ns MMP2: r = 0.57, p = 0.01
FD= flexor digitorum; n.s. = not significant; n.t. = not tested;
#fnumber of CTGF-immunopositive fibroblasts in epitendon were used for this correlation.
doi:10.1371/journal.pone.0071875.t001
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increased in reach limb tendons in our model, their increase in
serum indicate that another tissue is responding to the repetitive
loading with increased PDGF production. Future studies should
focus on determining its sources, such as in repetitively loaded
bones.
An increase in the collagenolytic gelatinase, MMP2, was evident
in both serum and forearm tendons of reach limbs of 18- and 24-
week HRLF rats. Hirata and colleagues have previously shown
increased MMP2 in flexor tendosynovial tissues collected from
patients with carpal tunnel syndrome, with higher MMP2 activity
in patients with a sudden exacerbation of symptoms [24]. MMP2
also increases in tendons after vertical jumping and treadmill
running, with greater increase in distal tendon regions (the same
region examined in this study) than in proximal tendon regions
[80]. MMPs are involved in collagen catabolism, and show
increased activity with high or low mechanical loading, particu-
larly when sustained over prolonged periods or during periods of
tendon repair after injury [80,81,82]. Increases of both TGFB1
and CTGF lead to an increase in MMP2 expression and fibroblast
activity in vivo [83]. The observed increase of MMP2 in reach limb
tendons support the presence of tendon degenerative processes
occurring as a result of long-term performance of this moderate
demand task. MMP2 has also been shown to increase the
conversion of TGFB1 precursor subunits to the active form of
TGFB1 [84]. The overall increase of MMP2 in reach limb
tendons and serum suggest that with continued task performance,
that more TGF-beta1 precursor proteins will be converted to its
active form, a conversion that is likely to lead to continued task-
induced fibrosis.
Lastly, these data are suggestive of multiple contributors to the
observed decline grip strength in the reach limbs. Increased
muscle inflammation, such as increased muscle TNF-a, is known
to reduce forearm grip strength [85,86,87]. In this study, and in
two prior studies, we have observed correlations between grip
strength declines and tissue/serum inflammatory cytokines
[42,44,46]. Patients with signs and symptoms of musculoskeletal
disorders (including reduced grip strength) also show increased
serum inflammatory cytokines that correlate with functional
impairments [2,3,4]. For example, serum levels of TNF-a, IL-1b
and IL-6 correlate positively with presence of musculoskeletal
disorders symptoms in patients, and TNF-a levels are even
predictive of symptom severity [2]. The temporal association
between grip strength declines and increased TGFB1, CTGF,
MMP2, and fibrotic tendon changes suggest that even fairly early
tissue fibrosis is contributing to motor declines. This is also
supported by prior work from our lab and others showing
increased fibrogenic proteins, musculotendinous fibrosis and
degenerative processes with prolonged exercise or repetitive
loading in animal models [35,37,48,51,55,63,64,65,71,88].
In conclusion, these findings show that even moderate demand
tasks can induce tissue degradative changes if the work is
performed for long periods of time. The temporal association of
grip strength declines with both low-grade tissue inflammatory
cytokine response and increased fibrotic/degradative proteins
support a contribution from each process to functional motor
declines occurring with overuse. Although further studies on
humans are needed, these findings suggest that serum levels of
TGFB1, CTGF and MMP2, and perhaps even hydroxyproline,
may serve as serum biomarkers of underlying tissue fibrogenic
changes in this rat model of work-related musculoskeletal
disorders, and that serum IL-6 may be a biomarker of either
musculotendinous inflammatory or fibrotic responses.
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